Clinical Trial

Evaluating the Efficacy of Voice Therapy for Neurogenic Voice Disorders

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this study is to evaluate the efficacy of voice therapy for neurogenic voice disorders. The main questions are: Does voice therapy improve patient-reported quality of life in speakers with neurogenic voice disorders? Does voice therapy improve listener perception of voice in speakers with neurogenic voice disorders? Does voice therapy improve acoustical analyses of voice in speakers with neurogenic voice disorders? Does voice therapy improve physiologic function in speakers with neurogenic voice disorders?
Trial Details
NCT Number NCT07474740
Lead Sponsor University of Texas at Austin
Conditions Speakers With Neurogenic Voice Disorders
Enrollment 40 participants
Start Date 2024-06-04
Primary Completion 2028-06-04 (estimated)
Study Completion 2028-06-04 (estimated)
Updated on ClinicalTrials.gov 2026-03-16